Browns Pharmaceuticals consists of two divisions as Veterinary pharmaceuticals and Human pharmaceuticals. The sector initially began venturing into the Veterinary industry with the marketing of Vetzyme, a pet animal vitamin range. It has gradually expanded over the years to Human Pharmaceuticals, Nutraceutical & cosmetics while introducing new and innovative medical devices to the health industry. Further, Browns Pharmaceuticals has adopted a product differentiation strategy to expand its veterinary product range to cater to a different customer segment by introducing Aqua and Diary/Diary Machinery products to the market. In Human Pharmaceuticals we are focused to venture into medical devices, cardiovascular, anti-diabetic and oncology product markets.